Urinary Bladder, Overactive

"Urinary Bladder, Overactive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.

Descriptor ID	D053201
MeSH Number(s)	C12.777.829.866 C13.351.968.829.813 C23.888.942.343.780
Concept/Terms	Urinary Bladder, Overactive Urinary Bladder, Overactive Overactive Bladder Overactive Urinary Bladder Bladder, Overactive Overactive Detrusor Overactive Detrusor Detrusor, Overactive Overactive Detrusor Function Detrusor Function, Overactive

Below are MeSH descriptors whose meaning is more general than "Urinary Bladder, Overactive".

Diseases [C]
Male Urogenital Diseases [C12]
Urologic Diseases [C12.777]
Urinary Bladder Diseases [C12.777.829]
Urinary Bladder, Overactive [C12.777.829.866]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urologic Diseases [C13.351.968]
Urinary Bladder Diseases [C13.351.968.829]
Urinary Bladder, Overactive [C13.351.968.829.813]
Pathological Conditions, Signs and Symptoms [C23]
Signs and Symptoms [C23.888]
Urological Manifestations [C23.888.942]
Lower Urinary Tract Symptoms [C23.888.942.343]
Urinary Bladder, Overactive [C23.888.942.343.780]

Below are MeSH descriptors whose meaning is related to "Urinary Bladder, Overactive".

Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder, Overactive".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Urinary Bladder, Overactive" by people in this website by year, and whether "Urinary Bladder, Overactive" was a major or minor topic of these publications.

Bar chart showing 5 publications over 5 distinct years, with a maximum of 1 publications in 2009 and 2015 and 2019 and 2022 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2009	1	1
2015	1	1
2019	1	1
2022	1	1
2023	1	1

Below are the most recent publications written about "Urinary Bladder, Overactive" by people in Profiles.

Shapiro K, Anger J, Cameron AP, Chung D, Daignault-Newton S, Ippolito GM, Lee U, Mourtzinos A, Padmanabhan P, Smith AL, Suskind AM, Tenggardjaja C, Van Til M, Brucker BM. Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin-A injection for overactive bladder: A multi-institutional collaboration from the SUFU Research Network (SURN). Neurourol Urodyn. 2024 Feb; 43(2):407-414.

View in: PubMed
Reynolds WS, Suskind AM, Anger JT, Brucker BM, Cameron AP, Chung DE, Daignault-Newton S, Lane GI, Lucioni A, Mourtzinos AP, Padmanabhan P, Reyblat PX, Smith AL, Tenggardjaja CF, Lee UJ. Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network. Neurourol Urodyn. 2022 02; 41(2):662-671.

View in: PubMed
Kopcsay KS, Marczak TD, Jeppson PC, Cameron AP, Khavari R, Tefera E, Gutman RE. Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial. Int Urogynecol J. 2022 04; 33(4):851-860.

View in: PubMed
Mourtzinos A. Editorial Comment. J Urol. 2019 03; 201(3):580.

View in: PubMed
Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Zylstra S, Kan F, Berg KC. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation. J Urol. 2018 01; 199(1):229-236.

View in: PubMed
Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation. Urology. 2016 Aug; 94:57-63.

View in: PubMed
Ellsworth P, Fantasia J. Solabegron: a potential future addition to the ?-3 adrenoceptor agonist armamentarium for the management of overactive bladder. Expert Opin Investig Drugs. 2015 Mar; 24(3):413-9.

View in: PubMed
Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Berg KC. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn. 2016 Feb; 35(2):246-51.

View in: PubMed
Ellsworth P, Travis M. Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder. Urol Nurs. 2014 Jul-Aug; 34(4):165-71.

View in: PubMed
O'Dell K. Pharmacologic management of bladder dysfunction in adult women. J Obstet Gynecol Neonatal Nurs. 2014 Mar-Apr; 43(2):253-63.

View in: PubMed

People

Explore

Similar Concepts

Top Journals